The complete exit of Mubadala removes a key activist catalyst that was pushing for a Just-Evotec Biologics carve-out IPO and board refresh. Without this pressure, the likelihood of near-term strategic actions diminishes. Monitor for any new activist filings or management's own strategic update to fill the void.
Price Chart
Executive Summary
Mubadala Investment Company PJSC and its affiliates have completely divested their entire stake in Evotec SE, selling 11,481,502 ordinary shares and 1 ADS on October 9, 2026, in a privately negotiated block trade at EUR 2.5109 per share. This exit eliminates a major activist investor that had been pushing for strategic changes including a carve-out IPO of Just-Evotec Biologics and board representation, removing a key catalyst for near-term shareholder value creation.
Key Financial Metrics
Key Facts
- Mubadala (via Ninety Fourth Investment Company) sold all 11,481,502 ordinary shares and 1 remaining ADS on October 9, 2026.
- Sale price was EUR 2.5109 per ordinary share in a privately negotiated block trade.
- The filing states the sale was to 'completely divest their investment in the Issuer'.
- Mubadala had previously held a ~7% stake and was pushing for a carve-out IPO of Just-Evotec Biologics and board representation.
- All reporting persons (Mubadala Investment Company, Mamoura Diversified Global Holding, Mubadala Technology Investments, ATIC Second International Investment Company, Ninety Fourth Investment Company) now hold 0% of Evotec SE.
Financial Impact
Complete exit of a ~7% activist shareholder; total sale proceeds approximately EUR 28.8 million based on 11,481,502 shares at EUR 2.5109.
Risk Factors
- Loss of activist pressure may slow restructuring and strategic initiatives.
- Block trade at EUR 2.5109 may signal limited near-term upside conviction from a sophisticated investor.
- Potential overhang from the block trade if not fully absorbed.
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001104659-26-115869 |
| Document: tm2627526d1_ex99-1.htm | 0001104659-26-115869 |
| Document: tm2627526d1_ex99-a2.htm | 0001104659-26-115869 |
| Document: tm2627526d1_ex99-a5.htm | 0001104659-26-115869 |
| Document: tm2627526d1_ex99-a4.htm | 0001104659-26-115869 |
| Document: tm2627526d1_ex99-a3.htm | 0001104659-26-115869 |
| Document: 0001104659-26-115869-index-headers.html | 0001104659-26-115869 |
| Document: 0001104659-26-115869-index.html | 0001104659-26-115869 |
| Document: 0001104659-26-115869.txt | 0001104659-26-115869 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 6-K | $1.42 $1.38 | ▲ +2.82% | ▲ +1.71% | $1.52 (−7.04%) |
Oct 14, 2026 13d ago | SC 13D/A | $1.42 $1.38 | ▲ +2.82% | ▲ +1.71% | $1.52 (−7.04%) |
Oct 14, 2026 13d ago | 6-K | $1.43 $1.42 | ▲ +0.35% | ▲ +0.64% | $1.52 (−6.67%) |
Sep 29, 2026 28d ago | 6-K | $1.64 $1.71 | ▲ +4.27% | ▲ +4.47% | $1.52 (−7.32%) |
Sep 9, 2026 6w ago | 6-K | $1.81 $1.77 | ▼ −2.21% | ▼ −1.61% | $1.52 (−16.02%) |
Aug 13, 2026 10w ago | 6-K | $2.02 $1.96 | ▲ +2.97% | ▲ +2.77% | $1.52 (+24.75%) |
Jul 13, 2026 15w ago | Press Release | $2.43 $2.14 | ▲ +11.93% | ▲ +12.29% | $1.52 (+37.45%) |
Jun 30, 2026 17w ago | 6-K | $2.80 $2.85 | ▲ +1.79% | ▲ +1.92% | $1.52 (−45.71%) |
Jun 17, 2026 18w ago | 6-K | $2.61 $2.56 | ▼ −1.92% | ▼ −2.70% | $1.52 (−41.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers